Earnings Feed
Start Free
COMMUNITY HEALTH SYSTEMS INC·4

Mar 3, 4:45 PM ET

HAMMONS KEVIN J 4

4 · COMMUNITY HEALTH SYSTEMS INC · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-03-01
COMMUNITY HEALTH SYSTEMS INCCYH
HAMMONS KEVIN J
CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-01+156,240→ 792,441 total
  • Award

    Common Stock

    [F2]
    2026-03-01+200,000→ 992,441 total
  • Tax Payment

    Common Stock

    2026-03-01$3.46/sh−96,896$335,260→ 895,545 total
  • Exercise/Conversion

    Performance Based Restricted

    [F1]
    2026-03-01−156,240→ 23,760 total
    Exercise: $0.00→ Common Stock (156,240 underlying)
  • Disposition to Issuer

    Performance Based Restricted

    [F1]
    2026-03-01−23,760→ 0 total
    Exercise: $0.00→ Common Stock (23,760 underlying)
  • Award

    Performance Based Restricted

    [F3]
    2026-03-01+400,000→ 400,000 total
    Exercise: $0.00→ Common Stock (400,000 underlying)
  • Award

    Stock Options (Right to Buy)

    [F4]
    2026-03-01+200,000→ 200,000 total
    Exercise: $3.46From: 2027-03-01Exp: 2036-02-29→ Common Stock (200,000 underlying)
Holdings

  • Performance Based Restricted

    [F5]
    Exercise: $0.00→ Common Stock (180,000 underlying)
    180,000

  • Performance Based Restricted

    [F6]
    Exercise: $0.00→ Common Stock (180,000 underlying)
    180,000

  • Stock Options (Right to Buy)

    Exercise: $4.99From: 2020-03-01Exp: 2029-02-28→ Common Stock (18,000 underlying)
    18,000

  • Stock Options (Right to Buy)

    Exercise: $4.93From: 2021-03-01Exp: 2030-02-28→ Common Stock (47,500 underlying)
    47,500

  • Stock Options (Right to Buy)

    Exercise: $8.81From: 2022-03-01Exp: 2031-02-28→ Common Stock (75,000 underlying)
    75,000

  • Stock Options (Right to Buy)

    Exercise: $10.18From: 2023-03-01Exp: 2032-02-29→ Common Stock (75,000 underlying)
    75,000

  • Stock Options (Right to Buy)

    Exercise: $6.15From: 2024-03-01Exp: 2033-02-28→ Common Stock (90,000 underlying)
    90,000

  • Stock Options (Right to Buy)

    [F4]
    Exercise: $2.87From: 2025-03-01Exp: 2034-02-28→ Common Stock (90,000 underlying)
    90,000

  • Stock Options (Right to Buy)

    [F4]
    Exercise: $3.01From: 2026-03-01Exp: 2035-02-28→ Common Stock (90,000 underlying)
    90,000
Footnotes (6)
  • [F1]The vesting of these 180,000 performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 86.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023 (156,240), and the remaining 13.2% of the target number has been forfeited (23,760).
  • [F2]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
  • [F3]The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.
  • [F4]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
  • [F5]The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
  • [F6]The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period.
Signature
Christopher G. Cobb, Attorney in Fact for Kevin J. Hammons|2026-03-03

Documents

2 files